Youth Drug Abuse, ADHD and Related Disorders

Ancestry (21)

  • ethnic - Participant ethnicity inferred from genotypes (phv00404445.v1.p1)
  • PC1 - First of ten principal components of ethnic ancestry (phv00404446.v1.p1)
  • pc1_newx100 - First of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404456.v1.p1)
  • PC10 - Tenth of ten principal components of ethnic ancestry (phv00404455.v1.p1)
  • pc10_newx100 - Tenth of ten principal components of ethnic ancestry *100 (to use as covariates in candidate gene analyses) (phv00404465.v1.p1)
  • PC2 - Second of ten principal components of ethnic ancestry (phv00404447.v1.p1)
  • pc2_newx100 - Second of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404457.v1.p1)
  • PC3 - Third of ten principal components of ethnic ancestry (phv00404448.v1.p1)
  • pc3_newx100 - Third of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404458.v1.p1)
  • PC4 - Fourth of ten principal components of ethnic ancestry (phv00404449.v1.p1)
  • pc4_newx100 - Fourth of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404459.v1.p1)
  • PC5 - Fifth of ten principal components of ethnic ancestry (phv00404450.v1.p1)
  • pc5_newx100 - Fifth of ten principal components of ethnic ancestry *100 (to use as covariates in candidate gene analyses) (phv00404460.v1.p1)
  • PC6 - Sixth of ten principal components of ethnic ancestry (phv00404451.v1.p1)
  • pc6_newx100 - Sixth of ten principal components of ethnic ancestry *100 (to use as covariates in candidate gene analyses) (phv00404461.v1.p1)
  • PC7 - Seventh of ten principal components of ethnic ancestry (phv00404452.v1.p1)
  • pc7_newx100 - Seventh of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404462.v1.p1)
  • PC8 - Eighth of ten principal components of ethnic ancestry (phv00404453.v1.p1)
  • pc8_newx100 - Eighth of ten principal components of ethnic ancestry*100 (to use as covariates in candidate gene analyses) (phv00404463.v1.p1)
  • PC9 - Nineth of ten principal components of ethnic ancestry (phv00404454.v1.p1)
  • pc9_newx100 - Nineth of ten principal components of ethnic ancestry *100 (to use as covariates in candidate gene analyses) (phv00404464.v1.p1)

Demographics (2)

Mental Health (6)

  • Affection_Status - Case control status of the subject for ADHD or drug abuse (phv00404411.v1.p1)
  • ALCHIWATERSYMCOU29 - Highest number of endorsed symptoms for alcohol use disorder PRIOR TO AGE 30 (phv00404415.v1.p1)
  • MJHIWATERSYMCOU29 - Highest number of endorsed symptoms for marijuana use disorder PRIOR TO AGE 30 (phv00404417.v1.p1)
  • PEIDEVIANTBEHAV - Pei-i scale Deviant Behavior. Past year. (phv00404423.v1.p1)
  • TOBSYMCOU - Symptom count for tobacco use disorder IN PAST 12 MONTHS (phv00404421.v1.p1)
  • TOBSYMCOUprior - Symptom count for lifetime tobacco use disorder prior to past year (phv00404422.v1.p1)

Race and Ethnicity (1)

Substance Use (7)

Other (29)

  • @5HTTLPR - Original 5-HTTLPR candidate gene score (long vs. short risk allele) (phv00404433.v1.p1)
  • @5HTTLPR_add - Additive coding of risk allele for 5-HTTLPR candidate gene, 0-1-2, 2 indicates the highest risk, 0 lowest risk (phv00404440.v1.p1)
  • ANALYTE_TYPE - Analyte Type (phv00404469.v1.p1)
  • BODY_SITE - Body site where sample was collected (phv00404467.v1.p1)
  • COMT - Original COMT snp score (phv00404434.v1.p1)
  • COMT_add - Additive coding of risk allele for COMT snp, 0-1-2, 2 indicates the highest risk, 0 lowest risk (phv00404441.v1.p1)
  • CONSENT - Consent group as determined by DAC (phv00404406.v1.p1)
  • DAT1 - Original DRD4 candidate gene score (phv00404431.v1.p1)
  • DAT1_2 - Original DAT1 candidate gene score recoded into long vs. short risk risk allele (phv00404432.v1.p1)
  • DAT1_add - Additive coding of risk allele for DAT1 candidate gene, 0-1-2, 2 indicates the highest risk, 0 lowest risk (phv00404439.v1.p1)
  • DRD2 - Original DRD2 snp score (phv00404435.v1.p1)
  • DRD2_add - Additive coding of risk allele for DRD2 snp, 0-1-2, 2 indicates the highest risk, 0 lowest risk (phv00404442.v1.p1)
  • DRD4 - Original DRD4 candidate gene score (phv00404429.v1.p1)
  • DRD4_2 - Original DRD4 candidate gene score recodedinto long vs. short risk risk allele (phv00404430.v1.p1)
  • DRD4_add - Additive coding of risk allele for DRD4 candidate gene, 0-1-2, 2 indicates highest risk, 0 lowest risk (phv00404438.v1.p1)
  • Gen_Risk - Summed score of the 6 candidate genes (MAOA_add2, DRD4_add, DATA1_add, @5HTTLPR_add, COMT_add, DRD2_add) (phv00404443.v1.p1)
  • gen_risk_missing - The number of missing candidate gene scores, if missing more than 1, than missing on Gen_Risk (phv00404444.v1.p1)
  • HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00404468.v1.p1)
  • IS_TUMOR - Tumor status (phv00404470.v1.p1)
  • MAOA - Original MAOA candidate gene score (phv00404427.v1.p1)
  • MAOA_2 - Original MAOA candidate gene score recoded into long vs. short risk risk allele (phv00404428.v1.p1)
  • MAOA_add - Additive coding of risk allele for MAOA candidate gene 0-1-2, 2 indicates highest risk, 0 lowest risk (phv00404436.v1.p1)
  • MAOA_add2 - Additive coding of risk allele for MAOA candidate gene, 0-2, excluding heterozygous females, 2 indicates highest risk, 0 lowest risk (phv00404437.v1.p1)
  • SAMPLE_ID - De-identified Sample ID (phv00404466.v1.p1)
  • SAMPLE_ID - Sample ID (phv00404408.v1.p1)
  • SAMPLE_USE - Sample Use (phv00404409.v1.p1)
  • SUBJECT_ID - De-identified Subject ID (phv00404410.v1.p1)
  • SUBJECT_ID - Subject ID (phv00404407.v1.p1)
  • SUBJECT_ID - Subject ID (phv00404405.v1.p1)